Ashland

Abstract Amorphous solid dispersions (ASDs) have been extensively utilized to improve the bioavailability of drugs that have low aqueous solubility....

Abstract Invasive pulmonary aspergillosis poses a significant threat to immunocompromised patients, characterized by high mortality rates. Posaconazole (PSZ), a second-generation...

Abstract Biotinidase deficiency is a rare inherited disorder characterized by biotin metabolism issues, leading to neurological and cutaneous symptoms that...

Abstract Background: Propranolol, largely prescribed as an antihypertensive and antiarrhythmic drug in pediatrics, is characterized by a bitter taste and...

Fast dissolving drug delivery systems offers a solution for pediatric, geriatric, mentally ill people and those patients having difficulty in...

Press Release Sept. 03, 2024 WILMINGTON, Del., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced it...

Abstract The increasing popularity of prolonged-release dosage forms, owing to their ability to provide continuous drug release after administration, has...

Press Release Supporting our globalize strategy to expand high-margin businesses, Ashland has completed the second expansion of its pharmaceutical injectables...

This study aimed to advance the development of intestinal colon-coated sustained-release matrix tablets of metronidazole for diverticulitis treatment, employing the...

In this study, the interaction among multifunctional excipients, including polysaccharides, cellulose derivatives, and surfactants, was particularly investigated, together with its...